• About us
    • About ImaBiotech
    • Our team
    • Quality Engagement
    • Careers
    • Contact Imabiotech
  • Innovative platforms
    • Overview of Technologies
    • Mass Spectrometry Imaging
    • Laser Microdissection
    • Multimaging™ Software
    • Spatially Resolved Gene Expression
    • High Multiplexing Proteins & Cell Markers
    • Testing Panels
  • Therapeutic areas
    • Oncology
    • Dermatology
    • Ophthalmology
    • Respiratory diseases
    • Central Nervous System
    • Metabolic Disorders
  • Services
    • Overview of Services
    • Biodistribution
    • Biomarkers Discovery
    • Formulation Screening
    • Digital Pathology Services
    • Drug Delivery
    • PK/PD-Pharmacology
    • Safety support
    • Translational Research
    • Clinical Drug Efficacy
  • Resources
    • Conferences and Webinars
    • Articles and research
    • Press releases & In the Press
    • Imabiotech news

Category: Oncology

oncology-resources

  • Imabiotech-oncology

    AACR-NCI-EORTC, International Conference on Molecular Targets and Cancer Therapeutics

  • immuno-oncology services and imaging

    SITC, Society for Immunotherapy of Cancer Congress

  • Oncology-Imaging-tumors-preclinical

    Target Exposure and Pharmacodynamics Study of the Indoleamine 2,3-Dioxygenase-1 (IDO-1) Inhibitor Epacadostat in the CT26 Mouse Tumor Model

  • AACR-oncology-Imabiotech-mass-spectrometry-imaging.png

    AACR 2019

  • French firms partner to provide pet cancer drug services

1 2 3 4 Next »

Search news




© ImaBiotech 2018-2022

Build Your Pathway